Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baptiste Pignon

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Brain, Behavior, and Immunity|February 1, 2026
From non-specific biomarker to targeted action: transdiagnostic and sex-specific drivers of high-CRP status in severe mental illness across the FondaMental Advanced Centers of Expertise (FACE) cohortsTim Rietberg, Susana Barbosa, Pieter Meysman, et al.
Schizophrenia Bulletin|May 24, 2024
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI StudyVera Brink, Humma Andleeb, Charlotte Gayer-Anderson, et al.
Schizophrenia Bulletin|May 19, 2021
The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings From the Multinational EU-GEI StudyBaptiste Pignon, Mohamed Lajnef, James B Kirkbride, et al.
Psychological Medicine|January 30, 2024
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI studyGiuseppe D'Andrea, Diego Quattrone, Kathryn Malone, et al.
Schizophrenia Research|October 15, 2022
Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortiumSophie E Smart, Deborah Agbedjro, Antonio F Pardiñas, et al.
Social Psychiatry and Psychiatric Epidemiology|June 19, 2023
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control studyLucia Sideli, Monica Aas, Diego Quattrone, et al.
Schizophrenia Bulletin|February 9, 2022
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI)Lucia Sideli, Adriano Schimmenti, Daniele La Barbera, et al.
Psychological Medicine|December 11, 2023
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control studyGiulia Trotta, Victoria Rodriguez, Diego Quattrone, et al.
Psychological Medicine|December 5, 2024
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studiesIsabelle Austin-Zimmerman, Edoardo Spinazzola, Diego Quattrone, et al.
JAMA Psychiatry|January 12, 2022
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in SchizophreniaAntonio F Pardiñas, Sophie E Smart, Isabella R Willcocks, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Brain, Behavior, and Immunity|February 1, 2026
From non-specific biomarker to targeted action: transdiagnostic and sex-specific drivers of high-CRP status in severe mental illness across the FondaMental Advanced Centers of Expertise (FACE) cohortsTim Rietberg, Susana Barbosa, Pieter Meysman, et al.
Schizophrenia Bulletin|May 24, 2024
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI StudyVera Brink, Humma Andleeb, Charlotte Gayer-Anderson, et al.
Schizophrenia Bulletin|May 19, 2021
The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings From the Multinational EU-GEI StudyBaptiste Pignon, Mohamed Lajnef, James B Kirkbride, et al.
Psychological Medicine|January 30, 2024
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI studyGiuseppe D'Andrea, Diego Quattrone, Kathryn Malone, et al.
Schizophrenia Research|October 15, 2022
Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortiumSophie E Smart, Deborah Agbedjro, Antonio F Pardiñas, et al.
Social Psychiatry and Psychiatric Epidemiology|June 19, 2023
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control studyLucia Sideli, Monica Aas, Diego Quattrone, et al.
Schizophrenia Bulletin|February 9, 2022
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI)Lucia Sideli, Adriano Schimmenti, Daniele La Barbera, et al.
Psychological Medicine|December 11, 2023
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control studyGiulia Trotta, Victoria Rodriguez, Diego Quattrone, et al.
Psychological Medicine|December 5, 2024
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studiesIsabelle Austin-Zimmerman, Edoardo Spinazzola, Diego Quattrone, et al.
JAMA Psychiatry|January 12, 2022
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in SchizophreniaAntonio F Pardiñas, Sophie E Smart, Isabella R Willcocks, et al.
Pageof 11